Opioid trial finds Teva Pharmaceuticals liable

By Helen Adams
Teva Pharmaceuticals and its affiliates found liable in opioid epidemic

Teva Pharmaceuticals and its affiliates have been found to be liable for accelerating the opioid epidemic, according to a New York jury.

The state's attorney general Laetitia James filed a lawsuit in 2019, accusing Teva - and other firms - of intensely marketing painkillers and ignoring the implications of addiction for consumers.


The underplayed the true dangers of opioids

New York State Attorney General Laetitia James said that Teva Pharmaceuticals - and its affiliates - had been found liable for "death and destruction" across the USA, by a jury. 

"Teva Pharmaceuticals USA and others misled the American people about the true dangers of opioids", stated James. 

However, Teva Pharmaceuticals has not accepted this and claims:

  • That it complied with all regulations (federal and state)
  • Teva Pharmaceuticals rejects that it used deceptive marketing to attract customers


In a statement, Teva Pharmaceuticals said "[We] strongly disagree with today's outcome and will prepare for a swift appeal as well as continue to pursue a mistrial".


The devastation of opioid addiction 

The exact damages Teva Pharmaceuticals will be forced to pay has yet to be decided.

Across the USA, over 3,000 lawsuits have been filed against various opioid producers, which claim that the public were misled by them, regarding the potential of drug addiction and abuse.

It is estimated that close to half a million people in the US have died from opioid overdoses over the past 20 years. 



Featured Articles

McKinsey: Consumers Demand Data-driven Wellness Products

New McKinsey Future of Wellness survey shows that consumers demand data-driven wellness solutions to improve health, sleep, nutrition, fitness & longevity

SpaceX Starlink Launch Boost for Indonesia Healthcare

As SpaceX CEO Elon Musk helps launch new satellite in Indonesia, we look at how the Starlink programme is improving healthcare provision in remote areas

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Johnson & Johnson takes collaborative approach to tackling the problem of carbon emissions in the global healthcare supply chain

Walgreens to Sell Over-the-Counter Opioid Overdose Drug

Medical Devices & Pharma

McKinsey Health Institute: Focus on Health Insights Body

Digital Healthcare

AstraZeneca & Celonis Map out Digital Transformation

Technology & AI